v3.26.1
Related-Party Transactions - Collaboration and License Agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 15, 2026
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Janssen Pharmaceuticals Inc | Asset Purchase Agreement            
Related-Party Transactions            
Service revenue - related party   $ 66,800   $ 3,700 $ 67,000 $ 5,600
Deferred revenue recognized   $ 66,836 $ 125 $ 1,600 66,800 $ 2,300
Service revenue based on cumulative progress         $ 100  
Research, Development And Other Assets            
Related-Party Transactions            
Upfront cash payment $ 25,000          
Research, Development And Other Assets | Janssen Pharmaceuticals Inc | Asset Purchase Agreement            
Related-Party Transactions            
Upfront cash payment 25,000          
Asset acquisition, consideration transferred, accounts receivable $ 3,300